CAZypedia needs your help!
We have many unassigned pages in need of Authors and Responsible Curators. See a page that's out-of-date and just needs a touch-up? - You are also welcome to become a CAZypedian. Here's how.
Scientists at all career stages, including students, are welcome to contribute.
Learn more about CAZypedia's misson here and in this article.
Totally new to the CAZy classification? Read this first.

Difference between revisions of "Carbohydrate Binding Module Family 101"

From CAZypedia
Jump to navigation Jump to search
(Created page with " <!-- RESPONSIBLE CURATORS: Please replace the {{UnderConstruction}} tag below with {{CuratorApproved}} when the page is ready for wider public consumption --> {{UnderConstruc...")
 
 
(12 intermediate revisions by 4 users not shown)
Line 1: Line 1:
  
 
<!-- RESPONSIBLE CURATORS: Please replace the {{UnderConstruction}} tag below with {{CuratorApproved}} when the page is ready for wider public consumption -->
 
<!-- RESPONSIBLE CURATORS: Please replace the {{UnderConstruction}} tag below with {{CuratorApproved}} when the page is ready for wider public consumption -->
{{UnderConstruction}}
+
{{CuratorApproved}}
 
* [[Author]]: [[User:Xuanwei Mei|Xuanwei Mei]]
 
* [[Author]]: [[User:Xuanwei Mei|Xuanwei Mei]]
 
* [[Responsible Curator]]:  [[User:Yaoguang Chang|Yaoguang Chang]]
 
* [[Responsible Curator]]:  [[User:Yaoguang Chang|Yaoguang Chang]]
Line 18: Line 18:
  
 
== Ligand specificities ==
 
== Ligand specificities ==
Mention here all major natural ligand specificities that are found within a given family (also plant or mammalian origin). Certain linkages and promiscuity would also be mentioned here if biologically relevant.
 
  
''Note: Here is an example of how to insert references in the text, together with the "biblio" section below:'' Please see these references for an essential introduction to the CAZy classification system: <cite>DaviesSinnott2008 Cantarel2009</cite>. CBMs, in particular, have been extensively reviewed <cite>Boraston2004 Hashimoto2006 Shoseyov2006 Guillen2010 Armenta2017</cite>.
+
[[File:Figure.png|thumb|'''Figure 1. Carbohydrate array assays of WfCBM101. ''' The binding of WfCBM101 to agarose and other galactans in red algae (A), and several other polysaccharides (B) was evaluated. κ-Car, κ-carrageenan. ι-Car, ι-carrageenan. Alg, alginate. An-FUC, sulfated fucan from ''Ascophyllum nodosum''. CSA, chondroitin sulfate A sodium salt. HA, hyaluronic acid. Pec, pectin. Three repeats were conducted for each polysaccharide.''' ]]
 +
 
 +
The first characterized member in the CBM101 family is WfCBM101 <cite>Mei2023</cite>. The CBM WfCBM101 bound to agarose and displayed a weak affinity to porphyran (Fig. 1). It was incapable of binding to the other polysaccharides that were examined, including κ-carrageenan, ι-carrageenan, alginate, sulfated fucan, chondroitin sulfate A sodium salt, hyaluronic acid, and pectin. Furthermore, WfCBM101 bound to agarose tetrasaccharide, but not to porphyran tetrasaccharide. It was reported porphyran consists of approximately 30% structural units of agarose <cite>Chi2012</cite>. It is thus speculated that the weak affinity of WfCBM101 for porphyran is attributed to the structural heterogeneity of porphyran.
  
 
== Structural Features ==
 
== Structural Features ==
''Content in this section should include, in paragraph form, a description of:''
+
An AlphaFold2 model predicts that WfCBM101 has a β-sandwich fold.
* '''Fold:''' Structural fold (beta trefoil, beta sandwich, etc.)
 
* '''Type:''' Include here Type A, B, or C and properties
 
* '''Features of ligand binding:''' Describe CBM binding pocket location (Side or apex) important residues for binding (W, Y, F, subsites), interact with reducing end, non-reducing end, planar surface or within polysaccharide chains. Include examples pdb codes. Metal ion dependent. Etc.
 
  
 
== Functionalities ==  
 
== Functionalities ==  
''Content in this section should include, in paragraph form, a description of:''
+
To evaluate the feasibility of WfCBM101 as a tool in the ''in situ'' investigation of porphyran, a fluorescent probe was constructed by fusing WfCBM101 with a green fluorescent protein. The ''in situ'' visualization of agarose in the red alga ''Gelidium amansii'' was realized by utilizing the fluorescent probe <cite>Mei2023</cite>.
* '''Functional role of CBM:''' Describe common functional roles such as targeting, disruptive, anchoring, proximity/position on substrate.
+
Taking WfCBM101 as the query sequence, 15 modules were retrieved from the NCBI database by the BLASTP program (E-value < e<sup>-5</sup>). There are eight modules adjacent to catalytic domains which are divided into the [[GH16]]_16 subfamily or [[GH86]] family. According to the CAZy database, the [[GH16]_16 subfamily and [[GH86]] family have members that degrade agarose. This implies that these eight modules might bind to agarose; however, this requires further investigation.
* '''Most Common Associated Modules:''' 1. Glycoside Hydrolase Activity; 2. Additional Associated Modules (other CBM, FNIII, cohesin, dockerins, expansins, etc.)
 
* '''Novel Applications:'''  Include here if CBM has been used to modify another enzyme, or if a CBM was used to label plant/mammalian tissues? Etc.
 
  
 
== Family Firsts ==
 
== Family Firsts ==
 
;First Identified
 
;First Identified
:Insert archetype here, possibly including ''very brief'' synopsis.
+
The first member WfCBM101 is a component of a GH86 β-agarase (unpublished data) from a marine bacterium ''Wenyingzhuangia fucanilytica'' CZ1127<sup>T</sup> <cite>Chen2016</cite>.
 
;First Structural Characterization
 
;First Structural Characterization
:Insert archetype here, possibly including ''very brief'' synopsis.
+
No experimentally determined three-dimensional structure has been solved in this CBM family.
  
 
== References ==
 
== References ==
 
<biblio>
 
<biblio>
#Cantarel2009 pmid=18838391
+
#Mei2023 pmid=38010608
#DaviesSinnott2008 Davies, G.J. and Sinnott, M.L. (2008) Sorting the diverse: the sequence-based classifications of carbohydrate-active enzymes. ''The Biochemist'', vol. 30, no. 4., pp. 26-32. [https://doi.org/10.1042/BIO03004026 DOI:10.1042/BIO03004026].
+
#Chi2012 pmid=22526785
#Boraston2004 pmid=15214846
+
#Chen2016 pmid=27220912
#Hashimoto2006 pmid=17131061
 
#Shoseyov2006 pmid=16760304
 
#Guillen2010 pmid=19908036
 
#Armenta2017 pmid=28547780
 
 
</biblio>
 
</biblio>
  
 
<!-- Do not delete this Category tag -->
 
<!-- Do not delete this Category tag -->
 
[[Category:Carbohydrate Binding Module Families|CBM101]]
 
[[Category:Carbohydrate Binding Module Families|CBM101]]
<!-- ATTENTION: Make sure to replace "nnn" with a three digit family number, e.g. "032" or "105" etc., for proper sorting of the page by family number. -->
 

Latest revision as of 23:56, 15 February 2024

Approve icon-50px.png

This page has been approved by the Responsible Curator as essentially complete. CAZypedia is a living document, so further improvement of this page is still possible. If you would like to suggest an addition or correction, please contact the page's Responsible Curator directly by e-mail.


CAZy DB link
https://www.cazy.org/CBM101.html

Ligand specificities

Figure 1. Carbohydrate array assays of WfCBM101. The binding of WfCBM101 to agarose and other galactans in red algae (A), and several other polysaccharides (B) was evaluated. κ-Car, κ-carrageenan. ι-Car, ι-carrageenan. Alg, alginate. An-FUC, sulfated fucan from Ascophyllum nodosum. CSA, chondroitin sulfate A sodium salt. HA, hyaluronic acid. Pec, pectin. Three repeats were conducted for each polysaccharide.

The first characterized member in the CBM101 family is WfCBM101 [1]. The CBM WfCBM101 bound to agarose and displayed a weak affinity to porphyran (Fig. 1). It was incapable of binding to the other polysaccharides that were examined, including κ-carrageenan, ι-carrageenan, alginate, sulfated fucan, chondroitin sulfate A sodium salt, hyaluronic acid, and pectin. Furthermore, WfCBM101 bound to agarose tetrasaccharide, but not to porphyran tetrasaccharide. It was reported porphyran consists of approximately 30% structural units of agarose [2]. It is thus speculated that the weak affinity of WfCBM101 for porphyran is attributed to the structural heterogeneity of porphyran.

Structural Features

An AlphaFold2 model predicts that WfCBM101 has a β-sandwich fold.

Functionalities

To evaluate the feasibility of WfCBM101 as a tool in the in situ investigation of porphyran, a fluorescent probe was constructed by fusing WfCBM101 with a green fluorescent protein. The in situ visualization of agarose in the red alga Gelidium amansii was realized by utilizing the fluorescent probe [1]. Taking WfCBM101 as the query sequence, 15 modules were retrieved from the NCBI database by the BLASTP program (E-value < e-5). There are eight modules adjacent to catalytic domains which are divided into the GH16_16 subfamily or GH86 family. According to the CAZy database, the [[GH16]_16 subfamily and GH86 family have members that degrade agarose. This implies that these eight modules might bind to agarose; however, this requires further investigation.

Family Firsts

First Identified

The first member WfCBM101 is a component of a GH86 β-agarase (unpublished data) from a marine bacterium Wenyingzhuangia fucanilytica CZ1127T [3].

First Structural Characterization

No experimentally determined three-dimensional structure has been solved in this CBM family.

References

  1. Mei X, Zhang Y, Jiang X, Liu G, Shen J, Xue C, Xiao H, and Chang Y. (2024). Discovery and characterization of a novel carbohydrate-binding module: a favorable tool for investigating agarose. J Sci Food Agric. 2024;104(5):2792-2797. DOI:10.1002/jsfa.13164 | PubMed ID:38010608 [Mei2023]
  2. Chi WJ, Chang YK, and Hong SK. (2012). Agar degradation by microorganisms and agar-degrading enzymes. Appl Microbiol Biotechnol. 2012;94(4):917-30. DOI:10.1007/s00253-012-4023-2 | PubMed ID:22526785 [Chi2012]
  3. Chen F, Chang Y, Dong S, and Xue C. (2016). Wenyingzhuangia fucanilytica sp. nov., a sulfated fucan utilizing bacterium isolated from shallow coastal seawater. Int J Syst Evol Microbiol. 2016;66(9):3270-3275. DOI:10.1099/ijsem.0.001184 | PubMed ID:27220912 [Chen2016]

All Medline abstracts: PubMed